NABULSI AZMI (Chief Operating Officer) sold 0.5% of their position (1.12K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $8.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/20/2024ACC: 0000950170-24-139063
Officer· Chief Operating Officer
Since Oct 2019
-1.12K
Net shares
Net seller
$8.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.12K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.12K
Price / share
$8.00
Trade value
$8.94K
% of position
0.5%
12/19/2024
240.42K→239.30K
Total
Net shares
−1.12K
Net value
-$8.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2024 | S · Sale | −1.12K | $8.00 | $8.94K | 0.5% | 240.42K | 239.30K |
| Total | −1.12K | -$8.94K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.58K
Common Stock
IndirectShares owned785.70K
Total
789.28K indirect789.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.58K | Indirect |
| Common Stock | 785.70K | Indirect |
| Total | 789.28K | 789.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported